Fresenius Medical Care AG
FMCQF
$49.21
$4.219.35%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.90B | 5.71B | 5.44B | 5.14B | 5.42B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.90B | 5.71B | 5.44B | 5.14B | 5.42B |
| Cost of Revenue | 4.29B | 4.26B | 4.06B | 3.89B | 4.07B |
| Gross Profit | 1.62B | 1.45B | 1.38B | 1.25B | 1.35B |
| SG&A Expenses | 913.38M | 824.74M | 898.84M | 789.98M | 894.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -31.32M | -3.14M | -11.50M | 8.51M | -29.58M |
| Total Operating Expenses | 5.21B | 5.12B | 4.99B | 4.74B | 4.98B |
| Operating Income | 689.18M | 586.57M | 447.62M | 401.71M | 435.51M |
| Income Before Tax | 591.90M | 470.65M | 397.85M | 263.77M | 190.93M |
| Income Tax Expenses | 123.91M | 87.95M | 88.82M | 64.24M | 65.02M |
| Earnings from Continuing Operations | 467.99M | 382.70M | 309.04M | 199.53M | 125.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -87.24M | -61.43M | -53.37M | -40.40M | -54.60M |
| Net Income | 380.75M | 321.27M | 255.67M | 159.14M | 71.31M |
| EBIT | 689.18M | 586.57M | 447.62M | 401.71M | 435.51M |
| EBITDA | 908.19M | 997.91M | 844.03M | 804.33M | 650.65M |
| EPS Basic | 1.33 | 1.10 | 0.87 | 0.54 | 0.24 |
| Normalized Basic EPS | 1.07 | 0.95 | 0.66 | 0.63 | 0.65 |
| EPS Diluted | 1.33 | 1.10 | 0.87 | 0.54 | 0.23 |
| Normalized Diluted EPS | 1.07 | 0.95 | 0.66 | 0.63 | 0.65 |
| Average Basic Shares Outstanding | 285.91M | 292.10M | 293.41M | 293.41M | 293.41M |
| Average Diluted Shares Outstanding | 285.91M | 292.10M | 293.41M | 293.41M | 293.41M |
| Dividend Per Share | 1.73 | -- | -- | -- | 1.54 |
| Payout Ratio | 0.00% | 0.00% | 187.56% | -- | 0.00% |